Open figure viewer
Significance
So far, only few treatments have shown benefit in clinical trials. The complexity of the disease means a ‘one treatment for all’ drug may still be a long way away from discovery. Meanwhile, effective triaging of patients and symptomatic management will remain important as trials proceed and newer drugs are screened.
Impacts
Two or three effective treatments may emerge in a few months for hospitalised patients.
Treatments for mild symptoms may take longer to arrive and may be less relevant if vaccinations are effective at preventing disease.
Multicentre clinical trials may be useful in assessing the standard-of-care for patients across countries.
© Oxford Analytica 2020. All rights reserved. This content contains general information about geopolitical, macroeconomic and social developments or (where stated) other matters. It does not contain advice or recommendations that may be relied on. Where links to external websites are provided, this does not indicate that Oxford Analytica or Emerald agree with, endorse or have checked for accuracy the contents of said sites.
2020
You do not currently have access to this content.
